logo
Plus   Neg
Share
Email

Stock Alert: Chiasma Up 8% On Positive Results From Acromegaly Treatment Trial

Shares of Chiasma, Inc. (CHMA) gained over 8% on Wednesday morning after reporting positive results from a late-stage trial of treatment for Acromegaly.

CHMA is currently trading at $4.37, up $0.33 or 8.17%, on the Nasdaq.

Chiasma, a biopharmaceutical company developing oral therapies for rare diseases, announced positive top-line data from its global Phase 3 non-inferiority clinical trial comparing Mycapssa to long-acting injectable somatostatin analogs in patients with acromegaly.

The study met its primary non-inferiority endpoint. 91% of patients on Mycapssa maintained insulin-like growth factor 1 response compared to compared to 100% on injectable SSAs.

The trial was designed to support a planned marketing authorization application for Mycapssa in the European Union.

Mycapssa is currently approved in the United States for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with injectable octreotide or lanreotide.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Fast-food giant McDonald's said it will be raising hourly wages for more than 36,500 hardworking employees at McDonald's-owned restaurants by an average of 10 percent to make it among the industry-leading pay and benefits package. These increases, which have already begun, will be rolled out over the next several months. Biogen Inc. (BIIB) Friday said its XIRIUS study of cotoretigene toliparvovec failed to meet its primary endpoint in Phase 2/3 in patients with X-linked retinitis pigmentosa or XLRP. The company further noted that the study obtained positive trends in other pre-specified clinically relevant endpoints,... General Mills Inc. (GIS) agreed to buy Tyson Foods' (TSN) pet treats business for $1.2 billion in cash, the companies said in a statement on Friday. The transaction includes the Nudges, Top Chews and True Chews brands. General Mills will also acquire a manufacturing facility in Independence, Iowa.
Follow RTT